SPONSOR
New York Medical College
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: Immune Thrombocytopenic PurpuraT-cell Acute Lymphoblastic LeukemiaT-Cell Acute Lymphoblastic LymphomaCovid19Non-hodgkin LymphomaHodgkin Lymphoma
New York Medical College is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Immune Thrombocytopenic Purpura, T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma, Covid19.
The trial portfolio spans Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — New York Medical College
How many clinical trials has New York Medical College sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by New York Medical College, of which 4 are actively recruiting participants. These trials cover conditions including Immune Thrombocytopenic Purpura, T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does New York Medical College research focus on?
New York Medical College clinical trials span Immune Thrombocytopenic Purpura, T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma, Covid19, Non-hodgkin Lymphoma, and additional conditions. The research pipeline includes Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a New York Medical College clinical trial?
To participate in a New York Medical College trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all New York Medical College trials with current recruitment status updated daily.
Clinical Trials by New York Medical College
NCT04323748 Phase 1
Recruiting
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
NCT04972942 Phase 1
Recruiting
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
T-cell Acute Lymphoblastic Leukemia
NCT04896606 Phase 1, Phase 2
Recruiting
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
Covid19
NCT05253495 Phase 2
Recruiting
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
Non-hodgkin Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology